Buy CJC-1295 Ipamorelin Blend UK | Growth Hormone Research Peptide
Buy CJC-1295 Ipamorelin Blend UK, a premium dual-peptide research compound supplied by Peptide House UK for laboratory research purposes only. Researchers frequently select this combination because both peptides support growth hormone signalling through separate yet complementary receptor pathways.
CJC-1295 acts as a growth hormone-releasing hormone (GHRH) analogue, while Ipamorelin functions as a selective growth hormone secretagogue that targets ghrelin receptors. Consequently, researchers often study this blend in advanced models focused on growth hormone pulsatility, IGF-1 signalling, endocrine function, and metabolic regulation.
Why Researchers Choose CJC-1295 Ipamorelin Blend
Researchers favour this combination because it brings together two of the most widely studied growth hormone peptides available. Furthermore, each peptide activates a different signalling pathway, creating a coordinated research model for analysing hormone release patterns.
In addition, the blend offers an opportunity to investigate both immediate and prolonged signalling responses within controlled laboratory environments.
- Dual-pathway growth hormone signalling research
- Growth hormone and IGF-1 pathway studies
- Endocrine system investigations
- Metabolic signalling research
- Performance and recovery-related peptide studies
- Peptide synergy and pharmacokinetic analysis
How CJC-1295 Ipamorelin Works (Research Context)
CJC-1295 is a modified form of GHRH (1-29) developed to increase stability and extend signalling activity. As a result, researchers frequently use it in studies involving prolonged growth hormone release patterns.
Ipamorelin, on the other hand, selectively targets ghrelin receptors (GHS-R1a). Therefore, it is often used to examine early-stage growth hormone signalling without significant interaction with other pituitary hormone pathways.
When researchers combine these peptides, they can analyse how dual receptor activation influences signalling efficiency, hormone pulsatility, and downstream IGF-1 activity.
- CJC-1295 supports extended signalling investigations
- Ipamorelin supports early-phase signalling models
- The combination enables dual-receptor pathway research
- Researchers can evaluate coordinated hormone responses
Key Research Applications
Growth Hormone Pathway Research
Researchers frequently study this blend in models involving growth hormone release and regulation. Moreover, the combination allows detailed analysis of receptor-specific activity and signalling duration.
- Growth hormone pulsatility studies
- Pituitary signalling investigations
- Hormone release pathway research
- GHRH receptor activity analysis
IGF-1 Signalling Research
Because growth hormone and IGF-1 pathways are closely connected, researchers commonly investigate this blend within broader endocrine signalling studies. Consequently, it remains one of the most popular peptide combinations in hormone-focused research environments.
- IGF-1 pathway investigations
- Cellular growth signalling studies
- Anabolic pathway research
- Hormonal communication models
Metabolic Research Models
Researchers also explore this blend in metabolic studies involving energy regulation and nutrient signalling. Furthermore, these pathways help scientists better understand interactions between hormones and metabolic function.
- Metabolic signalling studies
- Energy regulation research
- Endocrine-metabolic pathway analysis
- Hormonal adaptation investigations
Performance & Recovery Research
The CJC-1295 Ipamorelin combination is frequently included in performance-focused peptide research. As a result, researchers often analyse how growth hormone signalling influences recovery-related biological pathways.
- Recovery pathway investigations
- Performance peptide studies
- Exercise physiology research models
- Adaptive signalling analysis
Chemical Profile
- CJC-1295 Molecular Formula: C152H252N44O42
- CJC-1295 Molecular Weight: 3367.9 g/mol
- Alternative Name: Mod GRF 1-29
- Ipamorelin Molecular Formula: C38H49N9O5
- Ipamorelin Molecular Weight: 711.8 g/mol
- Alternative Name: NNC 26-0161
Why Buy from Peptide House UK?
- Premium research-grade peptides
- Strict quality control standards
- High-purity manufacturing processes
- Secure UK shipping and checkout
- Trusted UK peptide supplier
- Consistent batch-to-batch quality
Important Notice
CJC-1295 Ipamorelin Blend is supplied strictly for laboratory and scientific research purposes only. It is not intended for human consumption, medical use, diagnosis, or treatment.
Peptide House UK supplies research compounds exclusively for controlled laboratory environments and scientific investigation.




Reviews
There are no reviews yet.